The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
RNC training taking place in Corner Brook this weekend on West Valley Road, signage will be in place
Police find more than a kilogram of cocaine at a Deer Lake home, one man and two youth arrested
Police are looking for a snowmobile stolen from Stephenville
Bay of Islands Volunteer Search and Rescue putting a pause on new members to allow time to train
A convicted murderer from Corner Brook gets day parole
